Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal...

shared a link

2026-03-11 17:16:24 - Translate -

WWW.NATURE.COM

Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma

Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10244-wA clinical trial testing whether monitoring ctDNA clearance during treatment for nasopharyngeal cancer could be used to inform decisions about an individuals subsequent therapeutic programme shows promising results.

0 Comments 0 Shares 31 Views 0 Reviews